Research Studies

Addiction and Substance Abuse

IRB Number

Principal Investigator

Name of Study

03-128-1 Dr. Howard Tennen A Longitudinal Daily Process Examination of College Student Alcohol Use
09-053-1 Dr. Nancy Petry A SMART Design for Attendance-Based Prize CM
12-078H-3 Dr. Yifrah Kaminer Adaptive Treatment for Adolescent Cannabis Use Disorders
13-031-3 Dr. Lance Bauer Alcohol Risk Genes and Obesity Risk
07-108-2 Dr. Nancy Petry Brief Therapies for Frequent Gambling Substance Abusers
02-290-2 Dr. Mark Litt Combination Nicotine Replacement for Alcoholic Smokers
08-218-3 Dr. William White Contingency Management for Initiating Smoking Abstinence
08-053-2 Dr. Nancy Petry Contingency Management Treatment Duration
13-056-2 Dr. Jonathan Covault Dutasteride Treatment for the Reduction of Heavy Drinking
13-002-3 Dr. Cheryl Oncken Effects of Electronic Cigarettes
04-151-2 Dr. Robert Aseltine Emergency Department Alcohol Screening Project (Note: Grant Title is Alcohol Screening and Brief Intervention in the ED)
09-097-2 Dr. Cheryl Oncken Exercise for Smoking Cessation in Postmenopausal Women
05-239-2 Dr. Lance Bauer Genetic Versus Phenotypic Markers of Relapse Risk
07-035-3 Dr. Howard Tennen Marital Interaction in Alcoholic Couples Over Time
07-097-3 Dr. Cheryl Oncken Maternal Genetics, Cigarette Smoking, and Infant Birth Weight
09-050-3 Dr. Mark Litt Network Support for Alcohol Treatment: Mechanisms and Effectiveness
11-057-6 Dr. Cheryl Oncken Nicotine Replacement for Smoking Cessation During Pregnancy
089-89-1 Dr. Victor Hesselbrock Participating Center for Genetics of Alcoholism (Collaborative Study) COGA
06-217S-2 Dr. Jonathan Covault Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
11-036-2 Dr. Jonathan Covault Placebo Controlled Pilot Study of Dutasteride for the Reduction of Alcohol Use in Male Drinkers
10-010S-2 Dr. Nancy Petry Reinforcing Exercise in Cocaine Abusers
09-156-1 Dr. Nancy Petry Reward Center
08-082S-2 Dr. Howard Tennen Stress-Related College Drinking: Learned and Genetic Vulnerabilities
06-218S-2 Dr. Jonathan Covault Subjective and Physiological Effects of Alcohol: Role of Genetic Variation and Adrenal Hormones
06-162S-1 Dr. Jonathan Covault Subjective and Physiological Responses to Alcohol in Healthy Social Drinkers: Moderating Effect of Variation in GABRA2
07-155-2 Dr. Julian Ford Vocational Outcomes for Troubled Youth with Substance Abuse Problems and High HIV Risk (MST-CRAFT Vocational Outcomes Study)
13-066-3 Dr. Howard Tennen Vulnerabilities for Coping-Related Drinking among Post-College Young Adults


Child and Adolescent Psychiatry

IRB Number

Principal Investigator

Name of Study

10-109C-1 Dr. Daniel Connor An Open-Label Pilot Study of Guanfacine Extended Release for Traumatic Stress Related Overarousal Symptoms in Children with ADHD Symptoms with and Without PTSD
08-280-2 Dr. Julian Ford Assessment of Children in Outpatient Psychiatric Treatment
03-216-1 Dr. Julian Ford Contingency Management in MST
11-096-2 Dr. Julian Ford Developmental Diagnosis Study
12-077-3 Dr. Daniel Connor Information Technology Enabled Management System for Treatment of Adolescent Depression
07-123-2 Dr. Julian Ford Office of Juvenile Justice and Delinquency Prevention (OJJDP) Detention Study
02-016-1 Dr. Robert Aseltine Pathways from Childhood Adversity to Adult Mental Health
01-030-1 Dr. Karen Steinberg Prenatal Predictors of Risk for Child Maltreatment and the Role of Disorganized Attachment Patterns
10-117-2 Dr. Margaret Briggs-Gowan Preschool Disruptive Behavior and Family Stress Study
13-097-2 Dr. Julian Ford Screening for Poly-Victimization in Predicting a Range of Behavioral and Justice-Referred Youths Screened at Intake
11-063-1 Dr. Josephine Hawke VOICES: Gender Responsive Treatments for Girls


General and Adult Psychiatry

IRB Number

Principal Investigator

Name of Study

12-231-2 Dr. Jayesh Kamath A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy of Omega 3 Fatty Acid Augmentation of Desvenlafaxine Treatment of Major Depressive Disorder in Patients with Mental Illness
07-017-1 Dr. Julie Wagner Behavioral and Physiological Response to Race Related Stress in Diabetic Women
05-051S-1 Dr. Julian Ford Breaking the Cycle
10-118-2 Dr. Julian Ford Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
97-122-2 Dr. Howard Tennen Depression, Depression History and RA: A Daily Process Study
00-270-2 Dr. Julian Ford Evidence-Based Enhancement of the Detection, Prevention, and Treatment of Mental Illness in the Correction Systems
12-016H-2 Dr. Nancy Petry Exercise and Cognition
13-087-3 Dr. Jayesh Kamath Factors Influencing Fatigue in Breast Cancer Patients Undergoing Breast Irradiation
04-094-2 Dr. Julian Ford Neuroimaging Cognition in Post-Traumatic Stress Disorder
11-065O-6 Dr. Julie Wagner Stress Management Among Latinos with Type 2 Diabetes Mellitus


Geriatric and Older Adult Psychiatry

IRB Number

Principal Investigator

Name of Study

07-144-1 Dr. Richard Fortinsky Information and Help-Seeking Experiences Among Hispanic Family Caregivers
06-023-1 Dr. Julie Wagner Lifetime History of Major Depressive Disorder and Endothelial Function in Postmenopausal Women
13-048-6 Dr. David Steffens Neurobiology and Acute Treatment Outcomes of Late Life Depression
12-107-2 Dr. Lisa Barry Physical Functioning and Mental Health in Older Prisoners
10-071S-2 Dr. Richard Fortinsky Proactive Primary Dementia Care

Huntington's Disease

IRB Number

Principal Investigator

Name of Study

12-207-1 Dr. Carolyn Drazinic A Randomized, Double-blind Placebo-controlled Study to Assess the Safety and Tolerability, and the Efficacy of PBT2 in Patients with Early to Mid-stage Huntington Disease
10-016-1 Dr. Carolyn Drazinic Creatine Safety, Tolerability & Efficacy in Huntington's Disease (CREST-E)